Inmune Bio, Inc. — Investor Relations & Filings
Filings indexed
571
across all filing types
Latest filing
2026-04-23
Proxy Solicitation & In…
Country
US
United States of America
Listing
US
INMB
Inmune Bio, Inc. is a clinical-stage biotechnology company that develops therapies by reprogramming the patient's innate immune system to fight disease. The company's pipeline is focused on treating cancer and neurodegenerative disorders, particularly Alzheimer's disease. Its lead product candidates include XPro1595, a selective inhibitor of soluble Tumor Necrosis Factor (TNF) for treating neuroinflammation, and INKmune®, a tumor-agnostic therapy designed to prime a patient's natural killer (NK) cells to attack cancer. Inmune Bio's clinical development approach prioritizes matching a drug's mechanism of action to patient biology and using patient-centric outcome metrics.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| DEF 14A - Inmune Bio, Inc. (0001711754) (Filer) | 2026-04-23 | English | |
| 8-K - INMUNE BIO, INC. (0001711754) (Filer) | 2026-02-27 | English | |
| 8-K - INMUNE BIO, INC. (0001711754) (Filer) | 2026-02-23 | English | |
| 8-K - INMUNE BIO, INC. (0001711754) (Filer) | 2026-02-19 | English | |
| 8-K Filing | 2026-02-13 | English | |
| 8-K Filing | 2026-01-27 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 35868237 | DEF 14A - Inmune Bio, Inc. (0001711754) (Filer) | 2026-04-23 | English | ||
| 32897132 | 8-K - INMUNE BIO, INC. (0001711754) (Filer) | 2026-02-27 | English | ||
| 32897130 | 8-K - INMUNE BIO, INC. (0001711754) (Filer) | 2026-02-23 | English | ||
| 32897131 | 8-K - INMUNE BIO, INC. (0001711754) (Filer) | 2026-02-19 | English | ||
| 31423861 | 8-K Filing | 2026-02-13 | English | ||
| 31423822 | 8-K Filing | 2026-01-27 | English | ||
|
2025
9 filings
| |||||
| 13050483 | CURRENT REPORT | 2025-12-23 | English | ||
| 13050482 | CURRENT REPORT | 2025-12-19 | English | ||
| 13050485 | PROSPECTUS SUPPLEMENT | 2025-12-19 | English | ||
| 13050484 | CURRENT REPORT | 2025-12-10 | English | ||
| 13050486 | AMENDMENT NO. 5 TO FORM 8-A12B | 2025-12-08 | English | ||
| 13050488 | CURRENT REPORT | 2025-12-08 | English | ||
| 13050487 | CURRENT REPORT | 2025-12-05 | English | ||
| 13050492 | CURRENT REPORT | 2025-12-03 | English | ||
| 13050489 | Director's Dealing 2025 | 2025-12-02 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aura Biosciences, Inc.
Develops Virus-Like Drug Conjugates as targeted therapies f…
|
AURA | US | Manufacturing |
|
Aurinia Pharmaceuticals Inc.
Biopharmaceutical company developing therapies for severe a…
|
AUPH | CA | Manufacturing |
|
Aurisco Pharmaceutical Co.,Ltd.
Develops and manufactures complex APIs and intermediates wi…
|
605116 | CN | Manufacturing |
|
Aurobindo Pharma Ltd.
Vertically integrated developer and manufacturer of generic…
|
AUROPHARMA | IN | Manufacturing |
|
Auro Laboratories Ltd.
Manufactures WHO-GMP compliant APIs and intermediates, spec…
|
530233 | IN | Manufacturing |
|
Aurora Cannabis Inc.
Global producer and distributor of cannabis products for me…
|
ACB | CA | Manufacturing |
|
AURORA CANNABIS INC
Global producer and distributor of cannabis for medical and…
|
ACB | CA | Manufacturing |
|
AUTOBIO DIAGNOSTICS CO., LTD
Provides IVD solutions for immunoassay, microbiology, and m…
|
603658 | CN | Manufacturing |
|
Autolus Therapeutics plc
Biopharmaceutical company developing programmed T cell ther…
|
AUTL | GB | Manufacturing |
|
AVACTA GROUP PLC
Clinical-stage biotech developing targeted oncology drugs w…
|
AVCT | GB | Manufacturing |
Inmune Bio, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34518/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34518 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34518 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34518 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34518}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Inmune Bio, Inc. (id: 34518)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.